3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 2
5
Phase 1
3
Phase 2/3
2
Phase NA
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Recurrence Hepatocellular Carcinoma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
3
fludarabine
2
aldesleukin
2
Fluorouracil
2
spartalizumab
1
niraparib
1
fludarabine phosphate
1
entinostat
1
bintrafusp alfa protein, human
1
Tomography, X-Ray Computed
1
Therapeutics
1
SRA737
1
Papillomavirus Vaccines
1
NHS-IL12 immunocytokine
1
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin
1
Mitomycin
1
Magnetic Resonance Imaging
1
Leucovorin
1
Interleukin-2
1
Ibuprofen
1
Epinephrine
1
Electrocardiography
1
Diphenhydramine
1
Dexamethasone
1
Calcium Dobesilate
1
Biopsy
1
Adoptive Transfer
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Anus Neoplasms
×
Mitomycin
×
Clear all
NCT01671488
2020-02-17
276
Brown University
Phase 1/2
Terminated
11 enrolled
11 charts